Načítá se...

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Thyroid cancer is the most common endocrine malignancy, with over 60,000 cases reported per year in the US alone. The incidence of thyroid cancer has increased in the last several years. Patients with metastatic differentiated thyroid cancer (DTC) generally have a good prognosis. Metastatic DTC can...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Des Devel Ther
Hlavní autoři: Costa, Ricardo, Carneiro, Benedito A, Chandra, Sunandana, Pai, Sachin G, Chae, Young Kwang, Kaplan, Jason B, Garrett, Hannah B, Agulnik, Mark, Kopp, Peter A, Giles, Francis J
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778792/
https://ncbi.nlm.nih.gov/pubmed/27013865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S93459
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!